Cannabinoids: potential anticancer agents
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 3 (10) , 745-755
- https://doi.org/10.1038/nrc1188
Abstract
Cannabinoids - the active components of Cannabis sativa and their derivatives - exert palliative effects in cancer patients by preventing nausea, vomiting and pain and by stimulating appetite. In addition, these compounds have been shown to inhibit the growth of tumour cells in culture and animal models by modulating key cell-signalling pathways. Cannabinoids are usually well tolerated, and do not produce the generalized toxic effects of conventional chemotherapies. So, could cannabinoids be used to develop new anticancer therapies?Keywords
This publication has 106 references indexed in Scilit:
- Oral morphine and respiratory function amongst hospice inpatients with advanced cancerSupportive Care in Cancer, 2003
- Cachexia in cancer patientsNature Reviews Cancer, 2002
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B PathwayJournal of Biological Chemistry, 2002
- Δ9‐Tetrahydrocannabinol induces apoptosis in human prostate PC‐3 cells via a receptor‐independent mechanismFEBS Letters, 1999
- Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cellsFEBS Letters, 1998
- Abuse Potential of Dronabinol (Marinol®)Journal of Psychoactive Drugs, 1998
- Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of AdenylylcyclaseJournal of Medicinal Chemistry, 1997
- Cannabinoids enhance human B‐cell growth at low nanomolar concentrationsFEBS Letters, 1995
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964